MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain (Q75287675)
Jump to navigation
Jump to search
scientific article published on 17 January 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain |
scientific article published on 17 January 2004 |
Statements
MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain (English)
Dan Ilkovitch
Suzanne Ostrand-Rosenberg
17 January 2004